Association of Patient Care with Ventilator-Associated Conditions in Critically Ill Patients: Risk Factor Analysis

被引:11
|
作者
Nakahashi, Susumu [1 ,2 ]
Yamada, Tomomi [3 ]
Ogura, Toru [4 ]
Nakajima, Ken [5 ]
Suzuki, Kei [1 ,2 ]
Imai, Hiroshi [1 ,2 ]
机构
[1] Mie Univ Hosp, Dept Emergency, Tsu, Mie, Japan
[2] Mie Univ Hosp, Crit Care Ctr, Tsu, Mie, Japan
[3] Osaka Univ, Grad Sch Med, Dept Clin Epidemiol & Biostat, Suita, Osaka, Japan
[4] Mie Univ Hosp, Clin Res Support Ctr, Tsu, Mie, Japan
[5] Mie Univ, Sch Med, Dept Radiol, Tsu, Mie 514, Japan
来源
PLOS ONE | 2016年 / 11卷 / 04期
基金
日本学术振兴会;
关键词
RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; EVENTS; PNEUMONIA; SURVEILLANCE; PREVENTION; PREVENTABILITY; IMPLEMENTATION; DEFINITION; GUIDELINE;
D O I
10.1371/journal.pone.0153060
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Ventilator-associated conditions (VACs), for which new surveillance definitions and methods were issued by the Center for Disease Control and Prevention (CDC), are respiratory complications occurring in conjunction with the use of invasive mechanical ventilation and are related to adverse outcomes in critically ill patients. However, to date, risk factors for VACs have not been adequately established, leading to a need for developing a better understanding of the risks. The objective of this study was to explore care-related risk factors as a process indicator and provide valuable information pertaining to VAC preventive measures. Methods This retrospective, single-center, cohort study was conducted in the intensive-care unit (ICU) of a university hospital in Japan. Patient data were automatically sampled using a computerized medical records system and retrospectively analyzed. Management and care-related, but not host-related, factors were exhaustively analyzed using multivariate analysis for risks of VACs. VAC correlation to mortality was also investigated. Results Of the 3122 patients admitted in the ICU, 303 ventilated patients meeting CDC-specified eligibility criteria were included in the analysis. Thirty-seven VACs (12.2%) were found with a corresponding rate of 12.1 per 1000 ventilator days. Multivariate analysis revealed four variables related to patient care as risk factors for VACs: absence of intensivist participation in management of ventilated patients [adjusted HR (AHR): 7.325, P < 0.001)], using relatively higher driving pressure (AHR: 1.216, P < 0.001), development of edema (AHR: 2.145, P = 0.037), and a larger body weight increase (AHR: 0.058, P = 0.005). Furthermore, this research confirmed mortality differences in patients with VACs and statistically derived risks compared with those without VACs (HR: 2.623, P = 0.008). Conclusion Four risk factors related to patient care were clearly identified to be the key factors for VAC preventive measures.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Inhaled colistin for the treatment of ventilator-associated tracheobronchitis in critically ill patients
    Z Athanassa
    P Myrianthefs
    E Boutzouka
    V Papaioannou
    S Tsiplakou
    A Tsakris
    G Baltopoulos
    Critical Care, 15 (Suppl 1):
  • [32] Strategies to prevent ventilator-associated lung injury in critically Ill patients
    Joseph, Alex
    Khan, Muhammad Faisal
    Rajendram, Rajkumar
    INDIAN JOURNAL OF RESPIRATORY CARE, 2018, 7 (01) : 4 - 13
  • [33] Pharmacokinetics of inhaled colistin in critically ill patients with ventilator-associated tracheobronchitis
    Z Athanassa
    M Fousteri
    S Markantonis
    P Myrianthefs
    E Boutzouka
    E Tsigou
    A Tsakris
    G Baltopoulos
    Critical Care, 16 (Suppl 1):
  • [34] Treatment of Achromobacter Ventilator-Associated Pneumonia in Critically Ill Trauma Patients
    Wood, G. Christopher
    Jonap, Brittany L.
    Maish, George O., III
    Magnotti, Louis J.
    Swanson, Joseph M.
    Boucher, Bradley A.
    Croce, Martin A.
    Fabian, Timothy C.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (02) : 120 - 125
  • [35] Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia
    Benko, Ria
    Matuz, Maria
    Doro, Peter
    Peto, Zoltan
    Molnar, Anna
    Hajdu, Edit
    Nagy, Erzsebet
    Gardi, Janos
    Soos, Gyongyver
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (02) : 162 - 168
  • [36] Respiratory infection in the chronically critically ill patient - Ventilator-associated pneumonia and tracheobronchitis
    Ahmed, QAA
    Niederman, MS
    CLINICS IN CHEST MEDICINE, 2001, 22 (01) : 71 - +
  • [37] Lactobacillus species as a cause of ventilator-associated pneumonia in a critically ill trauma patient
    Wood, GC
    Boucher, BA
    Croce, MA
    Fabian, TC
    PHARMACOTHERAPY, 2002, 22 (09): : 1180 - 1182
  • [38] Treatment of Achromobacter Ventilator-Associated Pneumonia in Critically Ill Trauma Patients
    Jonap, Brittany
    Wood, G.
    Maish, George
    Magnotti, Louis
    Swanson, Joseph
    Boucher, Bradley
    Croce, Martin
    Fabian, Timothy
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [39] Antibiotic stewardship in critically ill patients with suspected ventilator-associated pneumonia
    Yoshimura, Jumpei
    Hashimoto, Hideki
    Yamakawa, Kazuma
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (20)
  • [40] Factors Predictive of Ventilator-associated Pneumonia in Critically Ill Trauma Patients
    Duraid Younan
    Sarah J. Delozier
    John Adamski
    Andrew Loudon
    Aisha Violette
    Jeffrey Ustin
    Glen Tinkoff
    Matthew L. Moorman
    Nathaniel McQuay
    World Journal of Surgery, 2020, 44 : 1121 - 1125